TMS Trial for Anorexia Nervosa: Promising Results in Body Perception

Recent Trial Shows Promise for Anorexia Nervosa Treatment

A recent randomized controlled trial has demonstrated that theta burst transcranial magnetic stimulation (TMS) targeting the extrastriate body area (EBA) can lead to significant improvements in body perception for patients with anorexia nervosa. This study, published on July 1, 2026, highlights a novel approach to addressing the challenging symptoms of this psychiatric disorder.

Anorexia nervosa is characterized by self-starvation, an intense fear of weight gain, and distorted body perception. Current treatments are limited, particularly for adults. The trial involved 40 participants with anorexia nervosa, divided into groups receiving either active TMS, sham TMS, or treatment-as-usual, along with a healthy control group. Results showed that those receiving active TMS experienced faster and sustained improvements in body perception over six months, as measured by the Body Shape Questionnaire.

Mechanism and Context of the Study

The extrastriate body area (EBA) is a cortical region implicated in body representation, making it a target for interventions aimed at recalibrating body perception. In this trial, active TMS was combined with body perception training, a dual approach that appears to enhance the therapeutic effects. The study found that active TMS altered EBA responses to self- versus non-self touch, aligning neural activity patterns more closely with those of healthy individuals.

This precision psychiatry approach, which integrates brain stimulation with behavioral training, underscores the potential of targeting disorder-relevant neural substrates for personalized therapeutic interventions. By linking neurobiological mechanisms to treatment, the study offers a promising direction for future research in psychiatric disorders.

Policy and Research Implications

The findings from this trial could inform future research and policy in the field of psychiatric treatment. If further validated, theta burst TMS could be integrated into treatment protocols for anorexia nervosa, potentially improving outcomes for patients who have not responded to traditional therapies. This study exemplifies how precision psychiatry can lead to more effective, individualized treatment strategies.

Moreover, the trial's success in demonstrating the efficacy of TMS in a clinical setting may encourage additional funding and support for similar research initiatives. Policymakers and healthcare providers might consider incorporating neuromodulation techniques into broader treatment frameworks for psychiatric disorders.

Risks and Unknowns

Despite the promising results, several risks and unknowns remain. The sample size of the trial was relatively small, and larger studies are needed to confirm these findings and assess the long-term safety and efficacy of TMS for anorexia nervosa. Additionally, the mechanism by which TMS affects neural activity in the EBA and its broader implications for body perception require further exploration.

There is also a need to evaluate the potential side effects and contraindications of TMS, particularly in vulnerable populations. Understanding these factors will be critical to ensuring that TMS can be safely and effectively integrated into clinical practice.

Future Directions

Looking forward, this trial paves the way for further research into the use of TMS and other neuromodulation techniques in treating psychiatric disorders. Future studies should aim to replicate these findings in larger, more diverse populations and explore the potential for combining TMS with other therapeutic modalities.

The integration of neurobiological insights into treatment strategies represents a significant step forward in the field of psychiatry. By continuing to explore the intersection of neuroscience and clinical practice, researchers and clinicians can develop more effective, personalized interventions for those suffering from anorexia nervosa and other complex disorders.